Dasatinib plus capecitabine for advanced breast cancer: Safety and efficacy in phase I study CA180004

1. Somlo, G.
2. Atzori, F.
3. Strauss, L.C.
4. Geese, W.J.
5. Specht, J.M.
6. Gradishar, W.J.
7. Rybicki, A.
8. Sy, O.
9. Vahdat, L.T.
10. Cortes, J.